Go.XMC.pl Muzyka WEB 2.0 - Palobiofarma completed the dose escalation part of the Phase I study with. : Epsilon mode

Play Music

Dodaj Link

.:: Opis ::.

1
Points
Palobiofarma completed the dose escalation part of the Phase I study with.
Dodany przez PatsyPrevo
Medibiofarma announced the nomination of a new Development Candidate, the compound MBF-118, a novel PPAR-y receptor antagonist for the treatment of bladder cancer. The compound will start IND enabling studies the second quarter 2018.
 
Temat: Instrumenty


.:: Komentarzy ::.



.:: Napisz Komentarz ::.

Prosze Zaloguj lub Rejestracja Zostaw komentarz


.:: Ads ::.

.:: QNews ::.

.:: Kategorie ::.

.:: Music News ::.